新型P2Y₁₂抑制剂 - Suppr

Suppr

超能文献

New P2Y₁₂ inhibitors.

作者信息

Storey Robert F

机构信息

Department of Cardiovascular Science, University of Sheffield, Sheffield S10 2RX, UK.

出版信息

Heart. 2011 Aug;97(15):1262-7. doi: 10.1136/hrt.2009.184242.

DOI:10.1136/hrt.2009.184242

PMID:21742618

Abstract

摘要

相似文献

New P2Y₁₂ inhibitors.

Heart. 2011 Aug;97(15):1262-7. doi: 10.1136/hrt.2009.184242.

Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target.

Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1607-16. doi: 10.1161/ATVBAHA.111.226373. Epub 2011 Apr 21.

Benzofuran-substituted urea derivatives as novel P2Y(1) receptor antagonists.

Bioorg Med Chem Lett. 2010 Jul 15;20(14):4104-7. doi: 10.1016/j.bmcl.2010.05.072. Epub 2010 Jun 9.

Functional interaction between purinergic receptors: effect of ligands for A2A and P2Y12 receptors on P2Y1 receptor function.

FEBS Lett. 2011 Dec 15;585(24):3978-84. doi: 10.1016/j.febslet.2011.10.050. Epub 2011 Nov 10.

Pharmacology and clinical trials of reversibly-binding P2Y12 inhibitors.

Thromb Haemost. 2011 May;105 Suppl 1:S75-81. doi: 10.1160/THS10-12-0769. Epub 2011 Apr 11.

Clopidogrel in acute coronary syndromes: where are we now?

Thromb Haemost. 2011 May;105(5):766-73. doi: 10.1160/TH10-10-0633. Epub 2011 Apr 7.

[Prasugrel--oral (Efient)].

J Pharm Belg. 2010 Dec(4):131-2.

Purinergic P2Y2 receptors mediate rapid Ca(2+) mobilization, membrane hyperpolarization and nitric oxide production in human vascular endothelial cells.

Cell Calcium. 2011 Apr;49(4):240-8. doi: 10.1016/j.ceca.2011.02.008. Epub 2011 Mar 16.

Ticagrelor for the treatment of arterial thrombosis.

Expert Opin Pharmacother. 2010 Sep;11(13):2251-9. doi: 10.1517/14656566.2010.511175.

SCH 602539, a protease-activated receptor-1 antagonist, inhibits thrombosis alone and in combination with cangrelor in a Folts model of arterial thrombosis in cynomolgus monkeys.

Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2143-9. doi: 10.1161/ATVBAHA.110.203414. Epub 2010 Aug 26.

引用本文的文献

Possible role of pannexin 1 channels and purinergic receptors in the pathogenesis and mechanism of action of SARS-CoV-2 and therapeutic potential of targeting them in COVID-19.

Life Sci. 2022 May 15;297:120482. doi: 10.1016/j.lfs.2022.120482. Epub 2022 Mar 11.

Quantification of unbound concentration of ticagrelor in plasma as a proof of mechanism biomarker of the reversal agent, MEDI2452.

PLoS One. 2018 Jul 26;13(7):e0201202. doi: 10.1371/journal.pone.0201202. eCollection 2018.

Acute coronary syndromes.

Clin Med (Lond). 2016 Dec;16(Suppl 6):s43-s48. doi: 10.7861/clinmedicine.16-6-s43.

Clopidogrel preserves whole kidney autoregulatory behavior in ANG II-induced hypertension.

Am J Physiol Renal Physiol. 2014 Mar 15;306(6):F619-28. doi: 10.1152/ajprenal.00444.2013. Epub 2014 Jan 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

New P2Y₁₂ inhibitors.

Heart. 2011 Aug;97(15):1262-7. doi: 10.1136/hrt.2009.184242.

Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target.

Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1607-16. doi: 10.1161/ATVBAHA.111.226373. Epub 2011 Apr 21.

Benzofuran-substituted urea derivatives as novel P2Y(1) receptor antagonists.

Bioorg Med Chem Lett. 2010 Jul 15;20(14):4104-7. doi: 10.1016/j.bmcl.2010.05.072. Epub 2010 Jun 9.

Functional interaction between purinergic receptors: effect of ligands for A2A and P2Y12 receptors on P2Y1 receptor function.

FEBS Lett. 2011 Dec 15;585(24):3978-84. doi: 10.1016/j.febslet.2011.10.050. Epub 2011 Nov 10.

Pharmacology and clinical trials of reversibly-binding P2Y12 inhibitors.

Thromb Haemost. 2011 May;105 Suppl 1:S75-81. doi: 10.1160/THS10-12-0769. Epub 2011 Apr 11.

Clopidogrel in acute coronary syndromes: where are we now?

Thromb Haemost. 2011 May;105(5):766-73. doi: 10.1160/TH10-10-0633. Epub 2011 Apr 7.

[Prasugrel--oral (Efient)].

J Pharm Belg. 2010 Dec(4):131-2.

Purinergic P2Y2 receptors mediate rapid Ca(2+) mobilization, membrane hyperpolarization and nitric oxide production in human vascular endothelial cells.

Cell Calcium. 2011 Apr;49(4):240-8. doi: 10.1016/j.ceca.2011.02.008. Epub 2011 Mar 16.

Ticagrelor for the treatment of arterial thrombosis.

Expert Opin Pharmacother. 2010 Sep;11(13):2251-9. doi: 10.1517/14656566.2010.511175.

SCH 602539, a protease-activated receptor-1 antagonist, inhibits thrombosis alone and in combination with cangrelor in a Folts model of arterial thrombosis in cynomolgus monkeys.

Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2143-9. doi: 10.1161/ATVBAHA.110.203414. Epub 2010 Aug 26.

引用本文的文献

Possible role of pannexin 1 channels and purinergic receptors in the pathogenesis and mechanism of action of SARS-CoV-2 and therapeutic potential of targeting them in COVID-19.

Life Sci. 2022 May 15;297:120482. doi: 10.1016/j.lfs.2022.120482. Epub 2022 Mar 11.

Quantification of unbound concentration of ticagrelor in plasma as a proof of mechanism biomarker of the reversal agent, MEDI2452.

PLoS One. 2018 Jul 26;13(7):e0201202. doi: 10.1371/journal.pone.0201202. eCollection 2018.

Acute coronary syndromes.

Clin Med (Lond). 2016 Dec;16(Suppl 6):s43-s48. doi: 10.7861/clinmedicine.16-6-s43.

Clopidogrel preserves whole kidney autoregulatory behavior in ANG II-induced hypertension.

Am J Physiol Renal Physiol. 2014 Mar 15;306(6):F619-28. doi: 10.1152/ajprenal.00444.2013. Epub 2014 Jan 29.

New P2Y₁₂ inhibitors.

作者信息

Storey Robert F

机构信息

Department of Cardiovascular Science, University of Sheffield, Sheffield S10 2RX, UK.

出版信息

Heart. 2011 Aug;97(15):1262-7. doi: 10.1136/hrt.2009.184242.

DOI:10.1136/hrt.2009.184242

PMID:21742618

Abstract

摘要